Key Takeaways
- • University of Toronto and McMaster University have partnered with Genesys Capital and Venture Ontario to establish the Genesys University Seed Fund, targeting early-stage life sciences startups in Ontario.
- • Genesys Capital, a Canadian life sciences venture capital firm with more than $400 million in cumulative investments, will oversee and manage the fund operations.
- • The initiative aims to retain university-affiliated life sciences spinouts within Ontario by providing accessible early-stage capital and reducing barriers to commercialization.
- • Major institutional support for the fund includes backing from RBC and the Temerty Foundation, alongside Venture Ontario's participation as a significant investor.
- • The fund's first close has been achieved, with expectations for continued growth and additional institutional participation in subsequent funding rounds.
Summary
University of Toronto and McMaster University have announced the launch of the Genesys University Seed Fund, a dedicated venture capital vehicle designed to support early-stage life sciences startups emerging from Canadian academic institutions. The fund was created in partnership with Genesys Capital, one of Canada's leading life sciences venture capital firms, and Venture Ontario, a provincial economic development organization.
Genesys Capital will serve as the fund's manager and overseer, bringing over $400 million in historical life sciences investments to the partnership. The creation of this fund addresses a critical gap in Ontario's life sciences ecosystem: retaining university-affiliated spinout companies that might otherwise relocate to other jurisdictions with more readily available seed-stage capital. By providing early-stage funding directly linked to university research institutions, the initiative aims to keep innovation and commercial activity within the province.
The fund has secured backing from major institutional investors, including RBC and the Temerty Foundation, alongside Venture Ontario's role as a principal investor. This multi-stakeholder approach reflects a coordinated effort to strengthen Ontario's position as a life sciences hub. According to available commentary, the achievement of first close represents a significant milestone, with stakeholders expressing confidence in the fund's ability to attract additional institutional participation in future funding rounds.
University of Toronto President Melanie Woodin has publicly engaged with the announcement, underscoring the institution's commitment to supporting commercialization of life sciences research. The fund structure specifically focuses on making it easier for university-affiliated life sciences startups to remain and scale operations within Ontario, addressing what has been identified as a leakage problem in Canada's innovation ecosystem where promising ventures have historically been forced to seek capital outside the country.
Genesys Capital will serve as the fund's manager and overseer, bringing over $400 million in historical life sciences investments to the partnership. The creation of this fund addresses a critical gap in Ontario's life sciences ecosystem: retaining university-affiliated spinout companies that might otherwise relocate to other jurisdictions with more readily available seed-stage capital. By providing early-stage funding directly linked to university research institutions, the initiative aims to keep innovation and commercial activity within the province.
The fund has secured backing from major institutional investors, including RBC and the Temerty Foundation, alongside Venture Ontario's role as a principal investor. This multi-stakeholder approach reflects a coordinated effort to strengthen Ontario's position as a life sciences hub. According to available commentary, the achievement of first close represents a significant milestone, with stakeholders expressing confidence in the fund's ability to attract additional institutional participation in future funding rounds.
University of Toronto President Melanie Woodin has publicly engaged with the announcement, underscoring the institution's commitment to supporting commercialization of life sciences research. The fund structure specifically focuses on making it easier for university-affiliated life sciences startups to remain and scale operations within Ontario, addressing what has been identified as a leakage problem in Canada's innovation ecosystem where promising ventures have historically been forced to seek capital outside the country.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.